August 27, 2018
NIH Director Francis S. Collins, M.D., Ph.D., keeps the public posted on fascinating NIH-supported research in biweekly posts on the NIH Director's Blog. The blog features the work of scientists from many of NIH's institutes and centers, as well as NIH grantees and collaborators, and NIAID is no exception.
August 09, 2018
New research from NIAID-funded scientists reveals that most individuals in a sample of West African Ebola survivors produced a unique subset of T cells called CD8+ T cells—also known as killer T cells.
June 29, 2018
Ebola vaccine concept could have broad use against several viruses.
June 25, 2018
The Democratic Republic of the Congo (DRC) is experiencing an outbreak of Ebola virus disease. As the U.S. government’s lead agency on biomedical infectious disease research, NIAID is providing several layers of support to the DRC and World Health Organization, which are leading a global, multi-sectoral response to the outbreak.
February 28, 2018
Dr. Erica Ollmann Saphire, speaker at the 2017 Joseph J. Kinyoun Memorial Lecture, has spearheaded a global effort to find antibodies that work against small-genomed viruses like Ebola and Lassa.
January 16, 2018
NIAID makes many resources available to researchers, such as reagents, model organisms, and tissue samples. Now it’s even easier to find these resources on our site using the Resources for Researchers feature.
December 19, 2017
Forty years on, survivors of the first Ebola outbreak provide new insights to researchers.
Critical Collaboration Agreements for Ebola Vaccine Candidates Earn NIAID an Excellence in Technology Transfer Award
November 13, 2017
In 2014, as the Ebola outbreak escalated, NIAID collaborated with pharmaceutical company GlaxoSmithKline on NIAID-planned clinical trials to test Ebola vaccine candidates. Their collaboration exemplifies the flexibility and creativity of the NIAID Technology Transfer and Intellectual Property Office, who developed unique and expedited agreements to facilitate the development of an Ebola vaccine.
November 03, 2017
A team of U.S. and Liberian scientists began a large study in Liberia, West Africa to examine how genes affect a person’s response to the Ebola virus. It remains unclear why some infections are asymptomatic and others are fatal, or why some people rapidly clear the infection and others remain in treatment for weeks. Investigators predict that genetic differences could influence these outcomes.